Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GYRE · against 1,372 other Healthcare companies
Ranked #890 of 1,373 · scores higher than 35% of peers · safety percentile 35
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 30–39, including GYRE · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GYRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.02× | 0.24× | 84% | 33% | |
| BetaLower is better · 1,320 reported | 4.74 | 0.53 | 0% | 33% | |
| Current ratioHigher is better · 1,338 reported | 4.26× | 2.62× | 68% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 886 | 285.2B USD | 35 | 63 | |
| 887 | 64.8B EUR (≈$71.3B) | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 51 |
| 888 | 326.5B KRW (≈$235M) | 35 | 52 |
| 889 | 3.3B CNY (≈$463M) | 35 | 26 |
| 890 | 471M USD | 35 | 21 |
| 891 | 7.1B CNY (≈$989M) | 35 | 38 |
| 892 | 4.0B USD | 35 | 56 |
| 893 | 11.4B CNY (≈$1.6B) | 35 | 50 |
| 894 | 4.61T JPY (≈$31.3B) | 35 | 76 |